Who founded AnaCardio?

AnaCardio was founded by Lars H. Lund.

Who are AnaCardio's investors?

AnaCardio's investors include 3B Future Health Fund, Industrifonden, Novo Holdings, Pureos Bioventures, Sound Bioventures.

How much funding has AnaCardio raised?

AnaCardio has disclosed $19M raised across 1 of its 2 known rounds.

Where is AnaCardio headquartered?

AnaCardio is headquartered in Stockholm, SE.

AnaCardio

Stockholm, SE · 5 known investors

Find your way into AnaCardio

AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development. The company was founded on breakthrough research from Karolinska Institutet targeting improved heart muscle contractility through a differentiated mechanism.

Biotech Healthtech Medical Devices

Founders & leadership

Lars H. LundFounder

Investors · 5

3B Future Health Fund✓ confirmed by AnaCardioMonaco · $12M

How we know: 3B Future Health Fund's portfolio page · the company's own site · Not right? Tell us

Industrifonden✓ confirmed by AnaCardioStockholm · $960K – $4.8M

How we know: Industrifonden's portfolio page · the company's own site · funding news · industrifonden.com · Not right? Tell us

Novo Holdings✓ confirmed by AnaCardioCopenhagen · $1.1M – $54M

How we know: Novo Holdings's portfolio page · the company's own site · funding news · Not right? Tell us

Pureos Bioventures✓ confirmed by AnaCardioPfäffikon

How we know: Pureos Bioventures's portfolio page · the company's own site · a partner's Signal profile · funding news · Not right? Tell us

Sound Bioventures✓ confirmed by AnaCardioMalmö

How we know: the company's own site · funding news · the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$19M disclosed across 1 of 2 rounds · 2022–2025

$19MraisedJan 2025 · 3 sources
Source ↗
Undisclosed amountseries A roundSep 2022
Industrifonden (lead)
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does AnaCardio do?: AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development. The company was founded on breakthrough research from Karolinska Institutet targeting improved heart muscle contractility through a differentiated mechanism.
Who founded AnaCardio?: AnaCardio was founded by Lars H. Lund.
Who are AnaCardio's investors?: AnaCardio's investors include 3B Future Health Fund, Industrifonden, Novo Holdings, Pureos Bioventures, Sound Bioventures.
How much funding has AnaCardio raised?: AnaCardio has disclosed $19M raised across 1 of its 2 known rounds.
Where is AnaCardio headquartered?: AnaCardio is headquartered in Stockholm, SE.